If your doctor has asked you to protect your muscle while on a GLP-1 medicine, the research gives useful context. Research on GLP-1 muscle loss finds that some lean tissue goes with any large weight loss, and the trial numbers measure more than muscle. Strength work and enough protein are the best-supported ways to keep strength.
Does Ozempic cause muscle loss?
When body weight drops substantially by any route, the body loses some lean tissue along with fat. A 2024 conceptual review, built on existing studies, explains that some fat-free mass loss is expected whenever fat tissue shrinks (Tinsley and Heymsfield, 2024). Fat tissue holds its own water and supporting structure, and a lighter body asks less of the muscles that carry it.
People taking semaglutide and similar medicines often lose a lot of weight. Lean mass falls along with fat, which is why questions about these medicines and muscle come up so often.
A 2024 review of MRI research concluded that muscle changes on GLP-1 medicines look adaptive (Linge et al., 2024). The changes matched the amount of weight lost, along with each person's age and health status.
That review is a primer, and its authors flagged older age and prefrailty as reasons for caution. Within those limits, losing some lean tissue during major weight loss is ordinary physiology. It says nothing about effort or character.
What the GLP-1 muscle loss trials actually measured
Lean mass and muscle are different measurements
Most body-composition figures in these trials come from DXA, a low-dose X-ray scan that sorts the body into fat mass and lean mass. Lean mass is a broad category. It includes skeletal muscle along with organs and water, and bone and connective tissue count toward it too.
A drop in lean mass is therefore a rough stand-in for muscle lost. The scan also says nothing about muscle quality, such as how much force a muscle produces.
How big the share was
A 2024 narrative review of trials in adults taking GLP-1-based weight-loss medicines looked at how much of the weight lost was lean mass. In some studies the share was 40% to 60% of total weight lost, and in others about 15% or less (Neeland et al., 2024). The authors note that older age and more severe disease may raise the risk of sarcopenia, so those groups warrant closer attention.
These percentages describe how results differed between trials. A spread that wide makes any single figure a poor guide for one person.
A systematic review of six semaglutide studies, covering 1,541 adults with overweight or obesity, finds that weight loss came mainly from fat (Bikou et al., 2024). Lean mass accounted for almost 0% to 40% of the total weight reduction. Some participants had type 2 diabetes and others did not.
The six studies differed in design, and the authors noted larger lean mass reductions in the larger trials. A single percentage quoted about glp 1 muscle loss can look more exact than it is. MRI adds nuance because it images muscle directly, and the review of that work read the changes as adaptive.
What is still unknown about strength and function
Strength shapes how daily life feels, from climbing stairs to lifting a suitcase. It is also the outcome the current evidence covers least clearly.
The 2024 MRI review closed by calling for better measures of muscle strength and function in future trials (Linge et al., 2024). Whether lower lean mass makes daily tasks harder remains an open question.
That uncertainty leaves a practical question about what helps in the meantime. A 2024 review names resistance training and higher protein intake as the main countermeasures studied during weight loss (Tinsley and Heymsfield, 2024).
Training and protein for keeping strength
Two kinds of study tested these countermeasures during weight loss, a randomized exercise trial and a meta-analysis of protein trials. Neither included people taking GLP-1 medicines, so their results apply to this group by extension.
What resistance training does during weight loss
A randomized trial enrolled 160 adults aged 65 and over with obesity, and 141 completed it (Villareal et al., 2017). Everyone followed a 6-month weight-management program and lost about 9% of body weight. One group added aerobic training and another added resistance training, while a third combined the two.
Among these older adults losing weight through diet, lean mass fell by 5% in the aerobic group. It fell by 3% with combined training and by 2% with resistance training. The groups that added strength work lost less lean mass than the group that did aerobic work alone.
Strength rose 19% with resistance training and 18% with the combined plan. Strength in the aerobic group rose by 4% over the same period, and physical function improved most with combined training, by 21%.
The weight loss in this trial came from diet, and everyone was 65 or older. Its results suggest a direction for GLP-1 users without proving the same effect.
Where protein fits
A meta-analysis pooled 20 randomized trials of older adults losing weight on purpose (Kim et al., 2016). It finds that those who ate higher-protein diets kept more lean mass and lost more fat. The trials used diet-based weight loss, and none tested protein alongside GLP-1 medicines.
Individual protein needs vary with body size and health. A gram target from a headline may not fit one person.
Strength work on low-energy days
Strength work fits into an ordinary room. Sit-to-stands from a sturdy chair train the legs, and push-ups against a wall load the arms and chest at a gentle angle.
Carrying grocery bags home is loaded work for your grip and trunk. Resistance bands add pulling movements for the upper back.
On a low-energy day, one short set keeps the habit alive. Over weeks, adding a few repetitions or lowering more slowly builds strength gradually. Getting up and moving between sessions keeps the habit going on the days in between.
Planning for GLP-1 muscle loss with your doctor
The right mix of training and protein depends on details only your care team sees. Appetite and kidney health both shape it, as do other conditions and how you feel from day to day.
Planning ahead helps most when appetite is low and energy dips. Deciding in advance where protein goes in your meals, and which days hold a short strength session, takes those choices off the hardest days.
Talk with the doctor who prescribes your medication before changing your exercise or protein intake. Raise new weakness or any fall with them promptly, and mention very low appetite or daily tasks that start to feel harder.
A small habit fits here. After each short strength session, we jot down which moves felt steady and which felt hard.
Sources
Neeland IJ et al., Diabetes, Obesity and Metabolism. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. 2024. doi.org
Bikou A et al., Expert Opinion on Pharmacotherapy. A systematic review of the effect of semaglutide on lean mass: insights from clinical trials. 2024. doi.org
Linge J et al., Circulation. Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?. 2024. doi.org
Tinsley GM and Heymsfield SB, Journal of the Endocrine Society. Fundamental Body Composition Principles Provide Context for Fat-Free and Skeletal Muscle Loss With GLP-1 RA Treatments. 2024. pmc.ncbi.nlm.nih.gov
Villareal DT et al., New England Journal of Medicine. Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults. 2017. pmc.ncbi.nlm.nih.gov
Kim JE et al., Nutrition Reviews. Effects of dietary protein intake on body composition changes after weight loss in older adults: a systematic review and meta-analysis. 2016. pmc.ncbi.nlm.nih.gov